Abnormal expression of connective tissue growth factor and its correlation with fibrogenesis in adenomyosis

Sha Wang, Wang S, Bohan Li, Li B, Duan H, Hua Duan, Yiyi Wang, Wang Y, Xue Shen, Shen X, Dong Q, Qianjing Dong
Reproductive BioMedicine Online · 2020 · vol. 42(3) , pp. 651–660 · doi:10.1016/j.rbmo.2020.11.002 · PMID:33431336 · W3099840674
article OA: closed CC0 ⤵ 9 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-11 ⓘ

This study investigated the expression of connective tissue growth factor (CTGF) in adenomyosis tissue and found it was abnormally expressed, correlating with fibrogenesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Research questionDoes connective tissue growth factor (CTGF) expression relate to adenomyotic fibrosis and determine the correlation between fibrosis with adenomyosis-associated dysmenorrhoea?DesignProtein and mRNA expression of CTGF was detected by Western blots and real-time quantitative polymerase chain reaction in the endometrium of the control group and the eutopic and ectopic endometrium of the adenomyosis group. Collagen fibres and type I collagen in the myometrium were detected by immunohistochemistry and Masson's trichrome staining, and the correlations of CTGF protein and mRNA levels with the degree of fibrosis were analysed. Furthermore, the relationship between the severity of dysmenorrhoea and the degree of fibrosis was determined, and the correlation between uterus size and the degree of fibrosis was also analysed.ResultsLevels of CTGF mRNA and protein were significantly higher in patients with adenomyosis than in controls, and CTGF mRNA and protein expression in adenomyosis was positively correlated with fibrosis severity (r = 0.57, P < 0.001 and r = 0.39, P = 0.012), which correlated positively with dysmenorrhoea and uterus size (r = 0.42 and r = 0.6, P < 0.002).ConclusionsIncreased CTGF may contribute to the occurrence and fibrogenic progression of adenomyosis and may play an important role in dysmenorrhoea. The present study may provide ideas for treating adenomyosis-associated dysmenorrhoea.

My notes (saved in your browser only)

Condition tags

dysmenorrheaadenomyosis

MeSH descriptors

Adenomyosis Connective Tissue Growth Factor Uterus Uterus Adenomyosis Adenomyosis Adenomyosis Adult Case-Control Studies Choristoma Choristoma Connective Tissue Growth Factor Dysmenorrhea Dysmenorrhea Dysmenorrhea Female Fibrosis Humans Middle Aged Organ Size

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (41)

Cited by (10)

Source provenance

europepmc
last seen: 2026-08-01T06:07:04.264727+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:25:00.839251+00:00
License: CC0 · commercial use OK